XML 54 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables present revenues, gross profit, operating income and amortization by reportable segment (in thousands):
 
Three Months Ended March 31, 2015
 
Apex
 
Oxford
 
Life Sciences Europe
 
Corporate
 
Total
Revenues
$
294,293

 
$
127,471

 
$
8,281

 
$

 
$
430,045

Gross profit
79,643

 
53,524

 
2,708

 

 
135,875

Operating income
22,911

 
15,353

 
392

 
(13,585
)
 
25,071

Amortization
3,522

 
1,300

 
47

 

 
4,869


 
Three Months Ended March 31, 2014
 
Apex
 
Oxford
 
Life Sciences Europe
 
Corporate
 
Total
Revenues
$
278,408

 
$
117,500

 
$
10,943

 
$

 
$
406,851

Gross profit
75,506

 
49,026

 
3,623

 

 
128,155

Operating income
22,784

 
14,284

 
1,322

 
(11,882
)
 
26,508

Amortization
4,089

 
1,370

 
71

 
8

 
5,538


Schedule of Revenue by Geographical Areas
The Company operates internationally, with operations mainly in the United States, Europe, and Canada. The following table represents revenues by geographic location (in thousands):
 
Three Months Ended
 
March 31,
 
2015
 
2014
Revenues:
 
 
 
Domestic
$
410,756

 
$
386,953

Foreign
19,289

 
19,898

 
$
430,045

 
$
406,851